Adzenys XR-ODT was approved by the U.S. Food and Drug Administration in January as a treatment for attention deficit hyperactivity disorder (ADHD) in children. Adzenys is a flavored amphetamine extended-release orally disintegrating tablet, designed to be more easily taken by children only once a day (usually in the morning).
But at least one psychiatrist is worried that the chewable, candy-like nature of the new drug may spell trouble toward over-medicating more children. And at least one psychiatrist worries that it could be a gateway drug for further prescription abuse.
Other psychiatrists, however, see the benefits of the new form of administration for the medication commonly prescribed to treat ADHD.